Glytec announced today that it expanded its collaboration with Roche to integrate software with smart diabetes technology. The two companies initially struck a partnership in early 2022. They aimed to combine Glytec’s FDA-cleared Glucommander insulin dosing decision support software with Roche’s expertise in medical devices and IT solutions. It marked an effort to address the […]
Roche
Roche wins CE mark for new AI-enabled CGM
Roche announced today that it received CE mark approval for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) system. CE mark approval covers the use of the CGM for people over 18 with type 1 and type 2 diabetes on flexible insulin therapy. The company first unveiled its Accu-Chek SmartGuide in an event at the Advanced […]
Roche, Genentech to reintroduce drug-eluting eye implant in U.S. following 2022 recall
Roche subsidiary Genentech today reintroduced its Susvimo therapy for delivery via ocular implant in the U.S. following a recall. The FDA approved a post-approval supplement to Susvimo’s Biologics License Application (BLA). Approval reflects component-level updates made to the ocular implant and refill needle. Roche now plans to work to make Susvimo available in the U.S. […]
Roche warns of software issues for its diabetes care platform
Roche Diabetes Care notified customers of a software bug that could lead to patient data mismatches on its RocheDiabetes Care platform. The RocheDiabetes Care platform offers a browser-based solution for visualizing and analyzing relevant therapy information. That could include glucose values, insulin, nutrition and activity data, helping to make treatment decisions for patients with diabetes. […]
Enable Injections, Roche expand enFuse delivery partnership
Enable Injections announced today that it expanded its collaboration with Roche to utilize its enFuse delivery technology in development programs. The partnership allows Roche to develop and apply Enable Injections’ expertise and enFuse technology to specific development programs. Through the collaboration, Roche can obtain a worldwide, exclusive license to develop and commercialize combinations of enFuse […]
The biggest diabetes tech news out of ATTD 2024
Catch up on the latest in diabetes tech from Dexcom, Abbott, Roche Diabetes Care, Insulet, Medtronic and Know Labs. Every year, the diabetes community comes together for the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). In this year’s 17th installment, some of the biggest names shared new studies and technologies set to […]
Roche unveils new CGM tech with predictive AI, outlines diabetes strategy
Roche today gave a presentation debuting its first continuous glucose monitor (CGM) offering that utilizes predictive AI. The company unveiled its Accu-Chek SmartGuide in an event at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Florence, Italy. It remains an investigational device not yet authorized for sale. Julien Boisdron, Roche Diabetes Care’s chief medical […]
How Glytec is advancing insulin management in the hospital
Growth and new partnerships have Glytec excited for the future of its Glucommander insulin dosing decision support software. After years of running a hospitalist group and mentoring hospitals on quality improvement, blood clot prevention and more, Dr. Jordan Messler found himself falling into a lot of work on diabetes. Messler cut his teeth on quality […]
Roche launches its connected blood glucose meter in Europe
Roche announced today that it launched its Cobas Pulse system in select countries accepting CE mark approval in Europe. Basel, Switzerland–based Roche designed its Cobas Pulse system to combine the form factor of a high-performance blood glucose meter with simple usability and expanded digital capabilities comparable to that of a smartphone. The platform joins Roche’s […]
Glytec partners with Roche to enhance insulin dosing decision support software
Glytec announced today that it entered into a strategic partnership with Roche Diagnostics USA for a digital health collaboration. Waltham, Massachusetts-based Glytec’s partnership combines its FDA-cleared Glucommander insulin dosing decision support software with Roche’s expertise in medical devices and IT solutions in an effort to address the challenges associated with inpatient blood sugar management at […]